https://www.healthcarepressmicronesia.com/article/864307285-spyre-therapeutics-announces-positive-interim-phase-1-results-for-spy003-its-novel-half-life-extended-anti-il-23-antibody
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life...